The pair of healthcare companies – Tempus Labs and Essex Woodland Healthcare partners, has acquired a 30 sq ft of leases at Helmsley Building on 75 Rockefeller plaza and Park avenue.
Tempus Labs, a chicago-based medical technology firm, has recently signed a 22,700 sq ft lease in the building located at 230 Park Avenue. The final deal was represented by Jordan Berger, along with Newmark Knight Frank’s Brian Waterman, Scott Klau, Erik Harris, Zachary Weil and Cole Gendels on behalf of RXR. CBRE’s Todd Lippman, Jared Isaacson and Alice Fair represented Tempus.
Scott Klau, a member of the real estate board of New York, says, “The fact that we were able to attract a technology tenant of Tempus‘ caliber in such a challenging leasing environment underscores the power of 230 Park Avenue’s attractive location, the building’s new modern infrastructure and the high-end, creative finishes of its new build outs.”
Another private equity firm, Essex Woodland Healthcare Partners, that is also a renowned investor in healthcare companies, has leased 7,500 sq ft in the same building on a different floor. Daniel Birney and Alexandra Budd handled the transaction for RXR in-house, along with Cushman & Wakefield’s Bruce Mosler, Tara Stacom, and Ethan Silverstein. NKF’s Josh Friedman and Cooper Weisman represented the tenant.
The news of recently leased building floors by the two companies has striked rumors for a future investment which will not only prove to be substantial for MedTech but also the investors. MedTech has been doing exponentially well in the field and investing in one such company during such a crucial time is going to bring more ROI to the investor firms.
Medtech is among the European voices of the medical technology Industries that has been slowly extending beyond Europe making it a good investment for the Essex Woodland Healthcare Partners. Considering the future of the healthcare sector across the globe, the industry has flooded with investments to not only benefit the partner firms but also the general public.